0
0.5
1
1.5
2+
Mortality
-22%
Improvement
Relative Risk
Mortality (b)
-21%
Ventilation
-55%
Ventilation (b)
-33%
HCQ for COVID-19 Gerlovin et al. LATE TREATMENT
Is late treatment with HCQ beneficial for COVID-19?
Retrospective 1,199 patients in the USA
Higher ventilation with HCQ (p=0.02)
c19hcq.org
Gerlovin et al., American J. Epidemiol.., Jun 2021
Favors HCQ
Favors control